AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 26292178
Drug: Individual cognitive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Individual cognitive stimulation therapy (iCST)
Trial: 2095341
Drug: Erythromycin stearate
RxNorm normalized name: Erythromycin Stearate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Erythromycin stearate (ES) 1000 mg
Trial: 2095341
Drug: Erythromycin acistrate
RxNorm normalized name: Erythromycin
DrugBank: Erythromycin (DB00199)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Erythromycin acistrate (EA) 800 mg
Trial: 27683800
Drug: Increased dosing
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Increased dosing to vedolizumab every 4 weeks (from every 8 weeks)
Trial: 19838998
Drug: Vitamin E
RxNorm normalized name: Vitamin E
DrugBank: Vitamin E (DB00163)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Vitamin E supplementation (133 mg or 200 IUs)
Trial: 14987324
Drug: Peginterferon plus
RxNorm normalized name: peginterferon alfa-2a Injection [Pegasys]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Peginterferon plus ribavirin combination therapy
Trial: 14987324
Drug: Baseline serum
RxNorm normalized name: Serum, horse
DrugBank: Serum, horse (DB14613)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Baseline serum interferon-gamma-inducible protein-10 levels greater than 299 pg/mL
Trial: 14987324
Drug: Baseline serum
RxNorm normalized name: Serum, horse
DrugBank: Serum, horse (DB14613)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Baseline serum interferon-gamma-inducible protein-10 levels lower than 299 pg/mL
Trial: 11476461
Drug: Pranlukast (225
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pranlukast (225 mg twice daily) in group 1p (N = 14)
Trial: 11476461
Drug: Pranlukast (225
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pranlukast (225 mg twice daily) in group 2p (N = 14)
Trial: 11476461
Drug: Pranlukast (225
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pranlukast (225 mg twice daily) in group 3p (N = 11)
Trial: 11476461
Drug: Conventional therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional therapy in groups 1c, 2c, and 3c (N = 24)
Trial: 9489812
Drug: Community based
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Community based physical therapy (PT) program, at least 4 visits or 3 hours of PT over 6 weeks
Trial: 3166359
Drug: Enoxacin 400
RxNorm normalized name: enoxacin 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enoxacin 400 mg administered orally or intravenously
Trial: 26096139
Drug: Abiraterone acetate
RxNorm normalized name: ABIRATERONE ACETATE
DrugBank: Abiraterone (DB05812)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Abiraterone acetate (1000 mg + 5 mg prednisone twice daily) + low-fat meal
Trial: 11481622
Drug: Triple antigen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Triple antigen vaccine
Trial: 9570610
Drug: Meperidine 40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Meperidine 40 mg (Group A)
Trial: 9570610
Drug: Meperidine 40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Meperidine 40 mg followed by naloxone 0.04 mg (Group B)
Trial: 9570610
Drug: Meperidine 40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Meperidine 40 mg followed by naloxone 0.2 mg (Group C)
Trial: 18608041
Drug: Atorvastatin 40-80
RxNorm normalized name: atorvastatin 80 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atorvastatin 40-80 mg/d
Trial: 18608041
Drug: Clopidogrel 300
RxNorm normalized name: clopidogrel 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clopidogrel 300 mg followed by 75 mg/d
Trial: 14711140
Drug: Intramuscular alefacept
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular alefacept 15 mg
Trial: 11044791
Drug: No medical
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No medical treatment (nontreated group)
Trial: 8259610
Drug: PRP-D vaccine
RxNorm normalized name: Hib (PRP-D)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PRP-D vaccine coadministered with Di-Te-Pol
Trial: 3862463
Drug: Intrathecal methotrexate
RxNorm normalized name: Methotrexate
DrugBank: Methotrexate (DB00563)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Intrathecal methotrexate plus intermediate dose methotrexate
Trial: 30478001
Drug: Azithromycin oral
RxNorm normalized name: azithromycin Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Azithromycin oral solution 10 mg/kg per day for 3 days
Trial: 18672400
Drug: PBT2 250
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PBT2 250 mg
Trial: 15467775
Drug: Orlistat, 120
RxNorm normalized name: Orlistat, 120 mg oral capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Orlistat, 120 mg three times daily with hypocaloric diet
Trial: 14650571
Drug: Experimental acupuncture
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Experimental acupuncture treatment (specific acupuncture body points related to menopausal symptoms)
Trial: 8072048
Drug: Experimental acupuncture
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Experimental acupuncture treatment
Trial: 14650571
Drug: Experimental acupuncture
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Experimental acupuncture treatment and Comparison acupuncture treatment
Trial: 4061000
Drug: Spinal anaesthesia
RxNorm normalized name: Bos taurus spinal cord preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Spinal anaesthesia with aspiration of 3 ml of CSF
Trial: 4061000
Drug: Spinal anaesthesia
RxNorm normalized name: Bos taurus spinal cord preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Spinal anaesthesia with a mixture of 3 ml of aspirated CSF and 3 ml of 0.5% isobaric bupivacaine
Trial: 21873358
Drug: Dabigatran 150
RxNorm normalized name: dabigatran 150 mg oral capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dabigatran 150 mg capsules
Trial: 21873358
Drug: Warfarin 5
RxNorm normalized name: warfarin 5 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Warfarin 5 mg tablets
Trial: 16286519
Drug: Calorie-restricted low-dairy
RxNorm normalized name: Beano Dairy Defense
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calorie-restricted low-dairy diet (CR) - approximately 1 serving dairy/day, 500 mg calcium/day
Trial: 9517760
Drug: 27.5 mg
RxNorm normalized name: lipase 27.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 27.5 mg folic acid supplementation per week
Trial: 2955205
Drug: Oestradiol valerate
RxNorm normalized name: Estradiol Valerate
DrugBank: Estradiol valerate (DB13956)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oestradiol valerate (2 mg/day)
Trial: 22117984
Drug: Combined inhalation
RxNorm normalized name: combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined inhalation and intravenous anaesthesia (sevoflurane 1.0 vol% in 50% air plus propofol‐remifentanil [target blood concentrations 1.5 ‐ 2.5 μg/ml and 2.5 ‐ 3.5 ng/ml])
Trial: 22117984
Drug: Sevoflurane (thiopental
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sevoflurane (thiopental sodium 4 ‐ 5 mg/kg and sevoflurane 2.0 ‐ 2.5 vol% in 50% air)
Trial: 9892883
Drug: Metoclopramide (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metoclopramide (10 mg)
Trial: 10940797
Drug: Inhaled budesonide,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled budesonide, 400 mug twice daily
Trial: 8365089
Drug: Soluble human
RxNorm normalized name: Recombinant soluble human CD4
DrugBank: Recombinant soluble human CD4 (DB17782)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Soluble human insulin (0.15 U kg‐1 body weight)
Trial: 6149992
Drug: Cimetidine (1,000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cimetidine (1,000 mg per day)
Trial: 2196208
Drug: Ranitidine (300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ranitidine (300 mg per day)
Trial: 6149992
Drug: Cimetidine (120
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cimetidine (120 mg per kg body weight)
Trial: 6149992
Drug: Ranitidine (120
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ranitidine (120 mg per kg body weight)
Trial: 23959571
Drug: Intensive Treatment
RxNorm normalized name: Uricalm Intensive
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intensive Treatment (IT)
Trial: 22108529
Drug: Coach-administered modified
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Coach-administered modified warm-up consisting of various swimming modes, intensities, and rest intervals for 20 minutes
Trial: 20698844
Drug: 0.1% DHEA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.1% DHEA cream
Trial: 8641599
Drug: Subcutaneous fluids
RxNorm normalized name: amniotic fluid (bovine)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subcutaneous fluids (s.c.)
Trial: 6095468
Drug: Intravenous gammaglobulin
RxNorm normalized name: Human gammaglobulin
DrugBank: Human immunoglobulin G (DB00028)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous gammaglobulin 100 mg/kg on 2 successive days
Trial: 29408986
Drug: Docetaxel (75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Docetaxel (75 mg/m2 every 3 weeks)
Trial: 25944156
Drug: 1 g
RxNorm normalized name: Molds 1 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 g topical TXA
Trial: 25944156
Drug: 2 g
RxNorm normalized name: Molds 2 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 g intravenous TXA
Trial: 22110105
Drug: Sodium excretion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sodium excretion > 7 g/day
Trial: 22110105
Drug: Potassium excretion
RxNorm normalized name: Potassium
DrugBank: Potassium (DB14500)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Potassium excretion 2-2.49 g/day
Trial: 20969563
Drug: Control (no
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (no topical agent)
Trial: 8612379
Drug: Diltiazem 60
RxNorm normalized name: DILTIAZEM 60MG 12HR CAP,SA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diltiazem 60 mg orally three times a day for 2 days
Trial: 26584404
Drug: 4g day(‐1)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4g day(‐1) paracetamol
Trial: 16362843
Drug: Sertraline with
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sertraline with late partial sleep deprivation
Trial: 9564184
Drug: Almitrine 75
RxNorm normalized name: almitrine
DrugBank: Almitrine (DB01430)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Almitrine 75 mg
Trial: 7701045
Drug: Ipsapirone 20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ipsapirone 20 mg
Trial: 29497863
Drug: Uric acid
RxNorm normalized name: Uric acid
DrugBank: Uric acid (DB08844)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Uric acid lowering treatment (specific intervention not detailed)
Trial: 26378067
Drug: 0.08 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.08 mg/kg oxycodone (Group O)
Trial: 26378067
Drug: 1 µg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 µg/kg fentanyl (Group F)
Trial: 23296279
Drug: Other antihypertensive
RxNorm normalized name: Other antihypertensives
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Other antihypertensive drugs (non-nitrate group)
Trial: 14633813
Drug: Control (NPH
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (NPH or MIX insulin)
Trial: 11077130
Drug: Sustained-release moxonidine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sustained-release moxonidine 0.9 mg bid
Trial: 8354296
Drug: Amoxicillin/clavulanate suspension
DrugBank: Amoxicillin (DB01060)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Amoxicillin/clavulanate suspension given b.i.d. for seven days
Trial: 8354296
Drug: Both treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both treatment groups (b.i.d. and t.i.d.)
Trial: 26492167
Drug: Ablation treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ablation treatment (coagulation) in Group A (small endometriomas)
Trial: 26492167
Drug: Excision treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Excision treatment in Group A (small endometriomas)
Trial: 26492167
Drug: Excision treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Excision treatment in Group B (large endometriomas)
Trial: 12488664
Drug: Standard course
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard course ciprofloxacin (15 mg/kg every 12 h for 5 days)
Trial: 9400449
Drug: Intracavernous injection
RxNorm normalized name: Bivalirudin 250 mg INTRACAVERNOUS INJECTION
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intracavernous injection of 10 micrograms alprostadil plus genital plus audiovisual sexual stimulation
Trial: 9400449
Drug: Re-dosing of
RxNorm normalized name: Re-Covr
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Re-dosing of 10 micrograms alprostadil
Trial: 7654128
Drug: Naltrexone hydrochloride
RxNorm normalized name: Naltrexone Hydrochloride
DrugBank: Naltrexone (DB00704)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Naltrexone hydrochloride 50 mg/d
Trial: 7654128
Drug: Naltrexone hydrochloride
RxNorm normalized name: Naltrexone Hydrochloride
DrugBank: Naltrexone (DB00704)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Naltrexone hydrochloride 100 mg (single dose)
Trial: 7654128
Drug: Naltrexone hydrochloride
RxNorm normalized name: Naltrexone Hydrochloride
DrugBank: Naltrexone (DB00704)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Naltrexone hydrochloride 150 mg/d
Trial: 2667598
Drug: Intravenous infusion
RxNorm normalized name: intravenous infusion pump accessory
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous infusion of CGP 38 560 A at doses of 50, 125, and 250 micrograms kg‐1
Trial: 7001331
Drug: Vidarabine therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vidarabine therapy
Trial: 28389705
Drug: Insulin infusion
RxNorm normalized name: iLet Insulin Infusion 10-Pack Kit Inset
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Insulin infusion (3.0/1.5 mU kg‐1 min‐1) under hyperglycaemic ketotic conditions (KET)
Trial: 28389705
Drug: Insulin infusion
RxNorm normalized name: iLet Insulin Infusion 10-Pack Kit Inset
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Insulin infusion (3.0/1.5 mU kg‐1 min‐1) under euglycaemic conditions (CTR)
Trial: 23122669
Drug: DEX 0.5
RxNorm normalized name: Stri-Dex 0.5 % Medicated Pad
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DEX 0.5 μg/kg (group D)
Trial: 21183500
Drug: Cardiac troponin
RxNorm normalized name: Cardiac troponin I
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cardiac troponin I (cTnI) ≥0.03 ng/mL
Trial: 21183500
Drug: Myeloperoxidase (MPO)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Myeloperoxidase (MPO) ≥670 pmol/L
Trial: 10357331
Drug: Controlled-release oxycodone
RxNorm normalized name: oxycodone
DrugBank: Oxycodone (DB00497)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Controlled-release oxycodone 20 mg every 12 h
Trial: 10357331
Drug: Immediate-release oxycodone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Immediate-release oxycodone 10 mg every 4 h
Trial: 10357331
Drug: Immediate-release oxycodone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Immediate-release oxycodone 10 mg every 4 h as needed
Trial: 7892519
Drug: Daily alcohol
RxNorm normalized name: Alcohol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Daily alcohol intake and nutrient intake
Trial: 7892519
Drug: Alcohol consumption
RxNorm normalized name: Alcohol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Alcohol consumption (more than 100 g ethanol per day)
Trial: 1974100
Drug: 5 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mg carvedilol i.v.
Trial: 333997
Drug: Single dose
RxNorm normalized name: Citrucel Single Dose Packets (Orange)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single dose of 0.5 mg terbutaline
Trial: 333997
Drug: Two consecutive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Two consecutive doses of 0.25 mg terbutaline
Trial: 333997
Drug: Four consecutive
RxNorm normalized name: Four-Way
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Four consecutive doses of 0.125 mg terbutaline
Trial: 29211735
Drug: Directed patrol
RxNorm normalized name: direct blue 2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Directed patrol by uniformed, unarmed security agents
Trial: 24499166
Drug: Egitromb 300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Egitromb 300 mg at admission followed by 8 days of 75 mg Egitromb daily (Group A, n = 28)
Trial: 24499166
Drug: Plavix 300
RxNorm normalized name: Plavix 300mg Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Plavix 300 mg at admission followed by 8 days of 75 mg Plavix daily (Group B, n = 25)
Trial: 22184293
Drug: Intraperitoneal normal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intraperitoneal normal saline infusion (INSI)
Trial: 9842842
Drug: Placebo (patches
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (patches and pills)
Trial: 2514676
Drug: Cicletanine 150
RxNorm normalized name: cicletanine
DrugBank: Cicletanine (DB12766)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cicletanine 150 mg/day
Trial: 412646
Drug: Glyceryl trinitrate
RxNorm normalized name: Glyceryl trinitrate
DrugBank: Nitroglycerin (DB00727)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Glyceryl trinitrate moulded tablet ('Nitrostat')
Trial: 412646
Drug: Generic compressed
RxNorm normalized name: Ulva compressa extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Generic compressed tablet
Trial: 30646205
Drug: IIDEA treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IIDEA treatment (10 sessions)
Trial: 10036952
Drug: One-week treatment
RxNorm normalized name: Gel-One
FDA approved: no
EMA approved: no
PMDA approved: no
Description: One-week treatment with LPZ 30 mg once daily, AMPC 1500 mg twice daily, CAM 800 mg twice daily
Trial: 12759560
Drug: 0.25 mg
RxNorm normalized name: biotin 0.25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.25 mg triazolam (TRZ)
Trial: 6989067
Drug: HRE (isoniazid,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HRE (isoniazid, rifampicin, ethambutol) for 2 months followed by H2R2 (isoniazid and rifampicin twice weekly) for 4 months
Trial: 6989067
Drug: HRSZ (isoniazid,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HRSZ (isoniazid, rifampicin, streptomycin, pyrazinamide) for 2 months followed by 4HRE (isoniazid, rifampicin, ethambutol daily) for 4 months
Trial: 6989067
Drug: Pyrazinamide included
RxNorm normalized name: Pyrazinamide
DrugBank: Pyrazinamide (DB00339)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Pyrazinamide included in the initial phase of treatment
Trial: 6989067
Drug: Overall treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Overall treatment regimens (6 months)
Trial: 16361729
Drug: Topical oxytetracycline
RxNorm normalized name: oxytetracycline Topical Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical oxytetracycline hydrochloride (tetracycline)
Trial: 9605061
Drug: Intravenous ergotamine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous ergotamine (0.25 mg)
Trial: 1620417
Drug: Famotidine 40
RxNorm normalized name: famotidine 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Famotidine 40 mg at 22 hours the night before surgery
Trial: 1620417
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (20 patients, no drugs)
Trial: 6431812
Drug: Hydralazine therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hydralazine therapy (100 mg orally every eight hours)
Trial: 29523533
Drug: Intravenous acetaminophen
RxNorm normalized name: Acetaminophen
DrugBank: Acetaminophen (DB00316)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous acetaminophen (1,000 mg/100 mL during surgery)
Trial: 26739997
Drug: UMEC 500
RxNorm normalized name: Umecta
FDA approved: no
EMA approved: no
PMDA approved: no
Description: UMEC 500 µg
Trial: 26739997
Drug: UMEC/VI 125/25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: UMEC/VI 125/25 µg
Trial: 26739997
Drug: UMEC/VI 500/100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: UMEC/VI 500/100 µg
Trial: 20406224
Drug: Moxifloxacin 400
RxNorm normalized name: moxifloxacin 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Moxifloxacin 400 mg (positive control)
Trial: 16770616
Drug: 1,000 mg
RxNorm normalized name: bran 1,000 mg ORAL WAFER
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1,000 mg ornidazole
Trial: 28222627
Drug: Ibuprofen 800
RxNorm normalized name: ibuprofen 800 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ibuprofen 800 mg three times daily
Trial: 9393572
Drug: Endoscopic laser
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Endoscopic laser therapy (ELT) only using a ND‐Yag Laser system (Group I and II)
Trial: 9393572
Drug: Endoscopic laser
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Endoscopic laser therapy (ELT) only (Group I and II)
Trial: 24986531
Drug: 75-g oral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 75-g oral glucose tolerance test (OGTT) and three isocaloric (500 kcal) and isovolaemic (350 ml) liquid meals with varying fat content (2.5g, 10g, 40g)
Trial: 484501
Drug: Oral quinidine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral quinidine
Trial: 9288408
Drug: Diazepam (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diazepam (10 mg)
Trial: 19667286
Drug: BAL8557 (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BAL8557 (100 mg isavuconazole) oral administration
Trial: 16449476
Drug: Continuation treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuation treatment (up to 1 year)
Trial: 16449476
Drug: Overall antidepressant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Overall antidepressant response
Trial: 3392892
Drug: Etomidate 2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Etomidate 2.5 mg/h
Trial: 3392892
Drug: Etomidate 0.3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Etomidate 0.3 mg/kg/h